Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its second quarter 2026 financial results on Wednesday, August 5, 2026, after U.S. market close.About Standard BioTools Inc.

Standard BioTools, Inc. (NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster.

For Research Use Only. Not for use in diagnostic procedures.

Limited Use Label License and other terms may apply: standardbio.com/legal/terms-and-conditions/.
Patent and License Information: standardbio.com/legal/notices.

Trademarks: standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2026 Standard BioTools Inc. (f.k.a. Fluidigm Corporation). All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Standard BioToolsLABNGS:LABbiotech investing
LAB
The Conversation (0)
Lahontan Drills 9.9m Grading 2.40 g/t Au and 50.7 g/t Ag in Santa Fe Mine Stockpile

Lahontan Drills 9.9m Grading 2.40 g/t Au and 50.7 g/t Ag in Santa Fe Mine Stockpile

Lahontan Gold Corp. (TSXV:LG,OTC:LGCXF, OTCQB:LGCXF, FSE:Y2F) (the "Company" or "Lahontan") is pleased to announce the first drill results from its 2026 Sonic core drilling program at the Santa Fe Mine Project. The Sonic drilling campaign is evaluating historic heap leach pads and stockpiles to... Keep Reading...
Lahontan Drills 31m Grading 0.90 g/t Au Oxide at Calvada Central

Lahontan Drills 31m Grading 0.90 g/t Au Oxide at Calvada Central

Lahontan Gold Corp. (TSXV:LG,OTC:LGCXF, OTCQB:LGCXF, FSE:Y2F) (the "Company" or "Lahontan") is pleased to announce additional drill results from its 2026 drilling program at the Santa Fe Mine Project. The drill results reported herein include 188 metres of diamond drilling at Calvada Central... Keep Reading...
New Found Gold Continues to Deliver High-Grade Gold at Queensway

New Found Gold Continues to Deliver High-Grade Gold at Queensway

23.7 g/t Au over 15.88 m from Lotto Channels43.5 g/t Au over 4.75 m from Lotto Underground Infill Drilling New Found Gold Corp. (TSXV: NFG) (NYSE American: NFGC) ("New Found Gold" or the "Company") is pleased to announce channel sample and infill drill results of Phase 2 open pit and underground... Keep Reading...
Brixton Metals Drills 5,015 g/t Silver over 20m in a New Brownfields Discovery Area at Its Langis Project

Brixton Metals Drills 5,015 g/t Silver over 20m in a New Brownfields Discovery Area at Its Langis Project

Included in hole 377 are several ultra-high-grade sub-intervals: 14.00m of 7,150 g/t silver, 1.15m of 74,137 g/t silver and0.65m of 89,125 g/t silver Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the "Company" or "Brixton") is pleased to report the discovery of ultra-high-grade silver... Keep Reading...
Star Copper Completes First Four Drill Holes Advancing District-Scale Discovery Strategy

Star Copper Completes First Four Drill Holes Advancing District-Scale Discovery Strategy

- Company moves beyond individual discovery to systematically validate district-scale exploration model VANCOUVER, BC / ACCESS Newswire / July 21, 2026 / Star Copper Corp. (CSE:STCU)(OTCQX:STCUF)(FWB:SOP) ("Star Copper" or the "Company"), a critical minerals exploration and development company,... Keep Reading...
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks in 2026

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has climbed back to multi-year highs in 2026, underscoring renewed strength in the biotech sector despite broader market volatility. As of July 7, the index stood at 6,856.74, up over 20 percent year-to-date. The rise shows that investors are... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

(TheNewswire) Kelowna, British Columbia July 6, 2026 TheNewswire Lexaria Bioscience Corp. (Nasdaq: LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at the 2026 BIO... Keep Reading...
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that dosing began on schedule on June 14th with Human Pilot Study #7 (GLP-1-H26-7) that is evaluating two oral... Keep Reading...
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following... Keep Reading...
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

More People Than Ever Taking GLP-1 Drugs for Weight Loss Growing List of Diseases Now Indicated as Treatable With GLP-1 Drugs KELOWNA, BC / ACCESS Newswire / June 17, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms,... Keep Reading...

Latest News

More News

Interactive Chart

Latest Press Releases

Non-Renounceable Entitlement Offer to Raise $2.5 Million

Aurum extends BDT2 gold beyond current resource

Phase 1 Metallurgy 98% Gold Recovery at Mt Solitary

Goldgroup Accelerates Growth Strategy Following Transformational Merger; Company Advances Multi-Asset Drill Programs, Mine Development and Expansion Plans

Related News

gold investing

Non-Renounceable Entitlement Offer to Raise $2.5 Million

gold investing

Aurum extends BDT2 gold beyond current resource

base metals investing

Phase 1 Metallurgy 98% Gold Recovery at Mt Solitary

precious metals investing

Goldgroup Accelerates Growth Strategy Following Transformational Merger; Company Advances Multi-Asset Drill Programs, Mine Development and Expansion Plans

vanadium investing

Top 3 Canadian Vanadium Stocks in 2026

oil and gas investing

Syntholene Energy Corp. Upsizes Private Placement to $2.0 Million and Announces Closing of First Tranche

energy investing

U92 Energy Announces Upsized Offering of up to $8 Million